Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5,029 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
WDR54 exerts oncogenic roles in T-cell acute lymphoblastic leukemia.
Li H, Zhang D, Fu Q, Wang S, Zhang X, Lin Z, Wang Z, Song J, Su Z, Xue V, Liu S, Chen Y, Zhou L, Zhao N, Lu D. Li H, et al. Among authors: zhao n. Cancer Sci. 2023 Aug;114(8):3318-3329. doi: 10.1111/cas.15872. Epub 2023 Jun 11. Cancer Sci. 2023. PMID: 37302808 Free PMC article.
YBX1 as an oncogenic factor in T-cell acute lymphoblastic leukemia.
Li H, Zhang D, Fu Q, Wang S, Wang Z, Zhang X, Chen X, Zhu X, An N, Chen Y, Zhou L, Lu D, Zhao N. Li H, et al. Among authors: zhao n. Blood Adv. 2023 Sep 12;7(17):4874-4885. doi: 10.1182/bloodadvances.2022009648. Blood Adv. 2023. PMID: 37339496 Free PMC article.
Selinexor Synergistically Promotes the Antileukemia Activity of Venetoclax in Acute Myeloid Leukemia by Inhibiting Glycolytic Function and Downregulating the Expression of DNA Replication Genes.
Jiang J, Wang Y, Liu D, Wang X, Zhu Y, Tong J, Chen E, Xue L, Zhao N, Liang T, Zheng C. Jiang J, et al. Among authors: zhao n. Immunotargets Ther. 2023 Nov 23;12:135-147. doi: 10.2147/ITT.S429402. eCollection 2023. Immunotargets Ther. 2023. PMID: 38026089 Free PMC article.
All-trans retinoic acid 45 mg/m2 is superior to 25 mg/m2 as the first induction regimen for the treatment of acute promyelocytic leukaemia: a retrospective analysis in a real-world clinical setting.
Zhang X, Feng S, Xu J, Zhao N, Hu X, Zhou L, Tong J, Xue L, Zhang L, Han Y, Wang X, Geng L, Zhu X, Tang B, Liu H, Zhu W, Cai X, Liu X, Sun Z, Zheng C. Zhang X, et al. Among authors: zhao n. Blood Cancer J. 2021 Jan 29;11(1):15. doi: 10.1038/s41408-021-00411-9. Blood Cancer J. 2021. PMID: 33514684 Free PMC article. No abstract available.
Standard-Intensity Induction and Intermediate/High-Dose Cytarabine Consolidation Can Improve Survival for Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia: A Retrospective Cohort Study.
Wang L, Zhao N, Zhou L, Tong J, Xue L, Zhang L, Han Y, Wang X, Geng L, Tang B, Liu H, Zhu W, Cai X, Liu X, Zhu X, Sun Z, Zheng C. Wang L, et al. Among authors: zhao n. Clin Interv Aging. 2022 Jan 20;17:55-64. doi: 10.2147/CIA.S343598. eCollection 2022. Clin Interv Aging. 2022. PMID: 35082491 Free PMC article.
High-dose cytarabine monotherapy is superior to standard-dose cytarabine- based multiagent sequential treatment cycle for consolidation treatment in adult (14-59 years) AML patients according to European Leukemia Net 2022 risk stratification.
Wang X, Liu D, Chen E, Wang L, Zhao N, Zhou L, Tong J, Xue L, Zhang L, Geng L, Tang B, Liu H, Liu X, Zheng C. Wang X, et al. Among authors: zhao n. Front Oncol. 2023 Jan 16;12:1070588. doi: 10.3389/fonc.2022.1070588. eCollection 2022. Front Oncol. 2023. PMID: 36727072 Free PMC article.
5,029 results